Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma.
about
Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapyThe Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trialA systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma.Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study.A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapyRisk stratification in the hormonal treatment of patients with prostate cancerMetabolic complications and increased cardiovascular risks as a result of androgen deprivation therapy in men with prostate cancer.Cardiometabolic and skeletal risk factors in black men with prostate cancer starting androgen deprivation therapy.Increased fat deposition in injured skeletal muscle is regulated by sex-specific hormones.Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer.Aging and hormones of the hypothalamo-pituitary axis: gonadotropic axis in men and somatotropic axes in men and womenIncreased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer.Metabolic sequelae associated with androgen deprivation therapy for prostate cancer.Perpetuating effects of androgen deficiency on insulin resistanceAndrogen regulation of prostate cancer: where are we now?Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis.Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanBody mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy.Cardiovascular Disease Risk Factors: How Relevant in African Men With Prostate Cancer Receiving Androgen-Deprivation Therapy?Effect of Androgen Deprivation Therapy on Bone Mineral Density in a Prostate Cancer Cohort in New Zealand: A Pilot Study.The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer.Information needs of cancer patients and survivors regarding diet, exercise and weight management: a qualitative study.Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.Adjuvant androgen deprivation therapy for prostate cancer treated with radiation therapy
P2860
Q26864943-2B569807-D22E-408F-B606-289EEB9319D8Q30587975-FF9F9C73-2615-4433-86F1-6CF70547A0D5Q33581390-30210C73-4D21-4F77-98C9-3BBA73CE631AQ33677118-49D8DAB7-D2E6-458D-AEDF-378C80599D59Q34079166-515A3AF2-7607-473E-BCD2-A9E218ABB803Q35076189-C15B02CC-4D89-462B-972E-646F88418A09Q35433102-39C1E471-D4F4-4FA4-B166-32BB33CCAFDFQ35614699-4954B664-0C87-46AF-8FDA-A52F8797D3F0Q35786748-AB176CD8-221F-4CA6-8A3A-07F5B72FA3D5Q36814324-D2F9D619-FAAA-4F6A-BACB-1B14A95BC41EQ36973105-D38E9950-0AE0-4BB4-B868-6A236FF22D47Q37331782-D8131490-3CF0-41D5-8970-7D6E26547947Q37431937-58D91201-5CAB-43D9-861C-52E8774141A9Q37478579-BDAF69ED-5CBA-4176-B8F9-66C71BD833BFQ37836264-35B087B8-ECF9-4ED2-A8D7-47B4B4415AE0Q38156703-A58092C9-98B2-4D70-8452-46DB53F3087EQ38186795-81137BDF-DB5D-4EF2-873D-11AD138A0724Q40431540-F10F8ECF-FA3D-418C-97FB-8CE38E6E886FQ40988056-02263E3C-8E39-49C3-B5AC-8A57D77B4AD5Q42375631-7AFBAA6F-437E-4322-9E85-53EE356359B0Q46877628-1B8DE3A0-8443-49A7-AF1E-929F82E193D3Q47196520-DB73D8C5-A7A3-4445-A1E1-B9968D07FE13Q52967287-248C78E0-8584-478B-89A6-EE96E1F1DC6BQ57112442-971495E0-AE71-441D-A16B-3F6EB195EB85
P2860
Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Low bone density and high perc ...... herapy for prostate carcinoma.
@en
Low bone density and high perc ...... herapy for prostate carcinoma.
@nl
type
label
Low bone density and high perc ...... herapy for prostate carcinoma.
@en
Low bone density and high perc ...... herapy for prostate carcinoma.
@nl
prefLabel
Low bone density and high perc ...... herapy for prostate carcinoma.
@en
Low bone density and high perc ...... herapy for prostate carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Low bone density and high perc ...... therapy for prostate carcinoma
@en
P2093
Bruce L Dalkin
Frederick R Ahmann
Michael Maricic
Paul Nguyen
P2860
P304
P356
10.1002/CNCR.10967
P407
P577
2002-11-01T00:00:00Z